Ondansetron given in the acute withdrawal from a repeated cocaine sensitization dosing regimen reverses the expression of sensitization and inhibits self-administration

Neuropsychopharmacology

Volumn 27, Issue 4, 2002, Pages 542-553

  Davidson, Colin ^a   Lee, Tong H ^a   Xiong, Zhiping ^a   Ellinwood, Everett H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cocaine; Ondansetron; Opponent processes; Self administration; Sensitization; Withdrawal

Indexed keywords

COCAINE; ONDANSETRON; SEROTONIN ANTAGONIST; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CATHETER; CONTROLLED STUDY; DOSE CALCULATION; DRUG DEPENDENCE; DRUG MECHANISM; DRUG SELF ADMINISTRATION; DRUG SENSITIZATION; GENDER; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; RATING SCALE; TIME; WITHDRAWAL SYNDROME;

ACUTE DISEASE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; COCAINE; COCAINE-RELATED DISORDERS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; DRUG TOLERANCE; MALE; MOTOR ACTIVITY; ONDANSETRON; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; SELF ADMINISTRATION; SEROTONIN ANTAGONISTS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0036790802     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(02)00336-6     Document Type: Article

References (76)

1. Arnold J.M., Roberts D.C.S. A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement. Pharmacol Biochem Beh. 57:1997;441-447.
2. Barros H., Miczek K.A. Withdrawal from oral cocaine in rats. ultrasonic vocalizations and tactile startle Psychopharmacol. 125:1996;379-384.
3. Breitinger H.G., Geetha N., Hess G.P. Inhibition of the serotonin 5-HT3 receptor by nicotine, cocaine, and fluoxetine investigated by rapid chemical kinetic techniques. Biochem. 40:2001;8419-8429.
4. Brown V.J., Latimer M.P., Winn P. Memory for the changing cost of reward is mediated by the sublenticular extended amygdala. Brain Res Bull. 39:1996;163-170.
5. 3 antagonist on drug-induced stimulation of dopamine release. Eur J Pharmacol. 164:1989;515-519.
6. Castanon N., Scearce-levie K., Lucas J.J., Rocha B., Hen R. Modulation of the effects of cocaine by 5-HT1B receptors. a comparison of knockouts and antagonists Pharmacol Biochem Beh. 67:2000;559-566.
7. 3 receptor antagonists do not modify cocaine place conditioning or the rise in extracellular dopamine in the nucleus accumbens of rats. Pharmacol Biochem Behav. 55:1996;33-37.
8. 3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res. 543:1991;353-357.
9. Chen J.G., Sachpatzidis A., Rudnick G. The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding. J Biol Chem. 272:1997;28321-28327.
10. Costall B., Domeney A.M., Naylor R.J., Tyers M.B. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain. Br J Pharmacol. 92:1987;881-894.
11. Costall B., Jones B.J., Kelly M.E., Naylor R.J., Onaivi E.S., Tyers M.B. Ondansetron inhibits a behavioral consequence of withdrawing from drugs of abuse. Pharmacol Biochem Beh. 36:1990;339-344.
12. Davidson C., Ellinwood E.H., Lee T.H. Altered sensitivity of dopamine autoreceptors in rat accumbens after intermittent or continuous cocaine withdrawal. Brain Res Bull. 51:2000;89-93.
13. Davidson C., Lazarus C., Lee T.H., Ellinwood E.H. Behavioral sensitization is greater after repeated versus single chronic cocaine dosing regimens. Eur J Pharmacol. 441:2002;75-78.
14. De Deurwaerdere P., Stinus L., Spampinato U. Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus. role of 5-HT3 receptors J Neurosci. 18:1998;6528-6538.
15. De La Garza R. II, Cunningham K.A. The effects of the 5-hydroxytryptamine1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin on spontaneous activity, cocaine-induced hyperactivity and behavioral sensitization. a microanalysis of locomotor activity J Pharm Exp Ther. 292:2000;610-617.
16. Depoortere R.Y., Li D.H., Lane L.D., Emmett-Oglesby M.W. Parameters of self-administration of cocaine in rats under a progressive ratio schedule. Pharmacol Biochem Behav. 45:1993;539-548.
17. De Vries T.J., Schoffelmeer A.N.M., Binnekade R., Mulder A.H., Vanderschuren L.J.M.J. Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioral sensitization. Eur J Neurosci. 10:1998;3565-3571.
18. Dworkin S.I., Mirkis S., Smith J.E. Response-dependent versus response-independent presentation of cocaine. differences in the lethal effects of the drug Psychopharmacol. 117:1995;262-266.
19. Ellinwood E.H., Balster R.I. Rating the behavioral effects of amphetamine. Eur J Pharmacol. 28:1974;35-41.
20. Ellinwood E.H., Molter D.W., Stauderman K.A. An assessment of spectral analysis of amphetamine-induced behavior. Pharmacol Biochem Behav. 15:1981;627-631.
21. Ellinwood E.H., Petrie W.M. Dependence on amphetamine, cocaine and other stimulants. Pradhan S.N. Drug Abuse. Clinical and Basic Aspects:1977;248-262 CV Mosby, St Louis, MO.
22. Felton M., Lyon D.O. The postreinforcement pause. J Exp Anal Behav. 9:1966;131-134.
23. Galici R., Pechnick R.N., Poland R.E., France C.P. Comparison of noncontingent versus contingent cocaine administration on plasma corticosterone levels in rats. Eur J Pharm. 387:2000;59-62.
24. Gawin F.H., Ellinwood E.H. Cocaine and other stimulants. actions, abuse and treatments New Eng J Med. 318:1988;1173-1181.
25. 3 receptor antagonists. Clinical pharmacology and therapeutic applications. Drugs. 53:1997;20-39.
26. Hemby S.E., Co C., Koves T.R., Smith J.E., Dworkin S.I. Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat. Psychopharmacol. 133:1997;7-16.
27. Hodos W. Progressive ratio as a measure of reward strength. Science. 134:1961;943-944.
28. Hooks M.S., Duffy P., Striplin C., Kalivas P.W. Behavioral and neurochemical sensitization following cocaine self-administration. Psychopharmacol. 115:1994;265-272.
29. Ikemoto S., Panksepp J. The role of nucleus accumbens dopamine in motivated behavior. a unifying interpretation with special reference to reward seeking Brain Res Rev. 31:1999;6-41.
30. 3 receptors control dopamine release in the nucleus accumbens of freely moving rats. Neurosci Lett. 101:1989;214-217.
31. 3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens. an in vivo chronocoulometric study Brain Res. 513:1990;156-160.
32. Johnson B.A., Ait-Daoud N. Neuropharmacological treatments for alcoholism. scientific basis and clinical findings Psychopharmacol. 149:2000;327-344.
33. Kankaanpaa A., Lillsunde P., Ruotsalainen M., Ahtee L., Seppala T. 5-HT3 receptor antagonist MDL 72222 dose-dependently attenuates cocaine-and amphetamine-induced elevations of extracellular dopamine in the nu- cleus accumbens and the dorsal striatum. Pharmacol Toxicol. 78:1996;317-321.
34. 3 receptors in the rat brain using radioligand binding. Nature. 330:1987;746-748.
35. King G.R., Joyner C., Lee T.H., Kuhn C., Ellinwood E.H. Jr. Intermittent and continuous cocaine administration. Residual behavioral states during withdrawal Pharmacol Biochem Behav. 43:1992;243-248.
36. 3 agonist-induced dopamine overflow during withdrawal from continuous or intermittent cocaine administration. Psychopharmacol. 117:1995;458-465.
37. 3 receptor antagonist, and cocaine. Psychopharmacol. 130:1997;159-165.
38. 3 receptor antagonist, administered during withdrawal from intermittent and continuous cocaine. Psychopharmacol. 135:1998;263-269.
39. 3 receptor antagonist. Eur J Pharmacol. 394:2000;97-101.
40. Koe B.K. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther. 199:1976;649-661.
41. Koob G.F., Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-723.
42. Koob G.F., Caine S.B., Parsons L., Markou A., Weiss F. Opponent Process model and psychostimulant addiction. Pharmacol Biochem Beh. 57:1997;513-521.
43. Lacosta S., Roberts D.C. MDL 72222, ketanserin, and methysergide pretreatments fail to alter breaking points on a progressive ratio schedule reinforced by intravenous cocaine. Pharmacol Biochem Beh. 44:1993;161-165.
44. Lane J.D., Pickering C.L., Hooper M.L., Fagan K., Tyers M.B., Emmett-Oglesby M.W. Failure of ondansetron to block the discriminative or reinforcing stimulus effects of cocaine in the rat. Drug Alcohol Depend. 30:1992;151-162.
45. 2 receptor antagonists on ethanol- and cocaine-induced locomotion. Pharmacol Biochem Behav. 57:1996;325-332.
46. Li Y., White F.J., Wolf M.E. Pharmacological reversal of behavioral and cellular indices of cocaine sensitization in the rat. Psychopharmacol. 151:2000;175-183.
47. Mair I.D., Lambert J.J., Yang J., Dempster J., Peters J.A. Pharmacological characterization of a rat 5-hydroxytryptamine type3 receptor subunit (r5-HT3A(b)) expressed in Xenopus laevis oocytes. Br J Pharmacol. 124:1998;1667-1674.
48. 3 receptor-mediated Bezold-Jarisch reflex in rats. Eur J Pharmacol. 315:1996;159-164.
49. 3 receptors - a patch clamp-study. Neuropeptides. 19:1991;25-30.
50. Mark G.P., Hajnal A., Kinney A.E., Keys A.S. Self-administration of cocaine increases the release of acetylcholine to a greater extent than response-independent cocaine in the nucleus accumbens of rats. Psychopharmacol. 143:1999;47-53.
51. 3 antagonist zacopride attenuates cocaine-induced increases in extra-cellular dopamine in rats nucleus accumbens. Pharmcol Biochem Behav. 45:1993;759-763.
52. Morrow B.A., Lee E.J.K., Taylor J.R., Elsworth J.D., Nye H.E., Roth R.H. S)-(-)-HA-966, a g-hydroxybutyrate-like agent, prevents enhanced mesocorticolimbic dopamine metabolism andbehavioral correlates of restraint stress, conditioned fear and cocaine sensitization. J Pharm Exp Ther. 283:1997;712-721.
53. Mutschler N.H., Miczek K.A. Withdrawal from a self-administered or non-contingent cocaine binge. differences in ultrasonic distress vocalizations in rats Psychopharmacol. 136:1998;402-408.
54. Mutschler N.H., Miczek K.A., Hammer R.P. Reduction of zif268 messenger RNA expression during prolonged withdrawal following "binge" cocaine self-administration. Neuroscience. 100:2000;531-538.
55. Neill D.B., Justice J.B. An hypothesis for a behavioral function of dopaminergic transmission in nucleus accumbens. Chronister R.B., De France J.F. The Neurobiology of the Nucleus Accumbens. 1981;343-350 Haer Institute, Brunswick, ME.
56. 3 antagonist, fails to alter cocaine self-administration in rats. Pharmacol Biochem Behav. 39:1991;133-136.
57. Phillips A.G., Di Ciano P. Behavioral sensitization is induced by intravenous self-administration of cocaine by rats. Psychopharmacol. 124:1996;279-281.
58. Pinelli A., Trivulzio S., Tomasoni L. Effects of on- dansetron on opioid withdrawal syndrome observed in rats. Eur J Pharmacol. 340:1997;111-119.
59. Rasmussen S.G.F., Carroll F.I., Maresch M.J., Jensen A.D., Tate C.G., Gether U. Biophysical characterization of the cocaine binding pocket in the serotonin transporter using a fluorescent cocaine analogue as a molecular reporter. J Biol Chem. 276:2001;4717-4723.
60. 3 receptor antagonists attenuate cocaine-induced locomotion in mice. Eur J Pharmacol. 186:1990;327-330.
61. Richardson N.R., Roberts D.C.S. Progressive ratio schedules in drug self-administration studies in rats. a method to evaluate reinforcing efficacy J Neurosci Meth. 66:1996;1-11.
62. Rocha B.A., Ator R., Emmett-Oglesby M.W., Hen R. Intravenous cocaine self-administration in mice lacking 5-HT1B receptors. Pharmacol Biochem Beh. 57:1997;407-412.
63. Rocha B.A., Fumagalli F., Gainetdinov R.R., Jones S.R., Ator R., Giros B., Miller G.W., Caron M.G. Cocaine self-administration in dopamine-transporter knockout mice. Nat Neurosci. 1:1998;132-137.
64. Roila F., Del Favero A. Ondansetron clinical pharmacokinetics. Clin Pharmacokinet. 29:1995;95-109.
65. Rosse R.B., Fay-McCarthy M., Collins J.P., Risher-Flowers D., Alim T.N., Deutsch S.I. Transient compulsive foraging behavior associated with crack cocaine use. Amer J Psychiat. 150:1993;155-156.
66. Rosse R.B., Fay-McCarthy M., Collins J.P., Alim T.N., Deutsch S.I. The relationship between cocaine-induced paranoia and compulsive foraging. a preliminary report Addiction. 89:1994;1097-1104.
67. Saynor D.A., Dixon C.M. The metabolism of ondansetron. Eur J Clin Oncol. 25:1989;S75-S77.
68. Scarpignato C., Pelosini I. Management of irritable bowel syndrome. novel approaches to the pharmacology of gut motility Canad J Gastronent. 13A:1999;50A-65A.
69. Schenk S., Partridge B. Sensitization and tolerance in psychostimulant self-administration. Pharmacol Biochem Beh. 57:1997;543-550.
70. Segal D.S., Mandell A.J. Long-term administration of d-amphetamine. Progressive augmentation of motor activity and stereotypy Pharmacol Biochem Behav. 2:1974;249-255.
71. Solomon R.L., Corbit J.D. An opponent-process theory of motivation. I. Temporal dynamics of affect. Psychological Rev. 81:1974;119-145.
72. Sora I., Wichems C., Takahashi N., Li X.F., Zeng Z., Revay R., Lesch K.P., Murphy D.L., Uhl G.R. Cocaine reward models. Conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice Proc Nat Acad Sci. 95:1998;7699-7704.
73. Suzuki T., Shiozaki Y., Masuukawa Y., Misawa I. 5-HT3 antagonists block cocaine- and methamphetamine-induced place-preference. Jap J Psychopharmacol. 12:1992;33-38.
74. Vanderschuren L.J., Kalivas P.W. Alterations in dopaminergic and glutaminergic transmission in the induction and expression of behavioral sensitization. a critical review of preclinical studies Psychopharmacol. 151:2000;99-120.
75. Wilson J.M., Nobrega J.N., Corrigall W.A., Coen K.M., Shannak K., Kish S.J. Amygdala dopamine levels are markedly elevated after self- but not passive-administration of cocaine. Brain Res. 668:1994;39-45.
76. Yoshimoto K., McBride W.J., Lumeng L., Li T.K. Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens. Alcohol. 9:1992;17-22.